Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT01891318
PHASE1/PHASE2

Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study

Sponsor: Case Comprehensive Cancer Center

View on ClinicalTrials.gov

Summary

This Phase I/II trial studies the ability to stop brain metastases from coming back after treatment with radiosurgery followed by surgical resection. It will also evaluate the side effects of these combined treatments and help determine the best radiosurgery dose. Radiosurgery focuses the x-rays directly to the tumor and cause less damage to the normal tissue in the brain.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2013-07-03

Completion Date

2025-12

Last Updated

2025-07-02

Healthy Volunteers

No

Interventions

RADIATION

radiosurgery

Undergo radiosurgery

PROCEDURE

therapeutic conventional surgery

Undergo surgical resection

PROCEDURE

quality-of-life assessment

Ancillary studies

Locations (2)

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Cleveland, Ohio, United States

Cleveland Clinic, Case Comprehensive Cancer Center

Cleveland, Ohio, United States